-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GmM62raEchjGncMvWXInPFM2tNgHJTWMhWeBuPCAAHlnMDC+FEKQxcozyWwI9TIP Zxgb48RE2rteU/ueEfot1w== 0000733337-97-000051.txt : 19971205 0000733337-97-000051.hdr.sgml : 19971205 ACCESSION NUMBER: 0000733337-97-000051 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19970925 ITEM INFORMATION: FILED AS OF DATE: 19971204 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOPHARMACEUTICS INC CENTRAL INDEX KEY: 0000733337 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133186327 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-09370 FILM NUMBER: 97732163 BUSINESS ADDRESS: STREET 1: 990 STATION RD CITY: BELLPORT STATE: NY ZIP: 11713 BUSINESS PHONE: 5162865800 MAIL ADDRESS: STREET 1: 990 STATION ROAD CITY: BELLPORT STATE: NY ZIP: 11713 FORMER COMPANY: FORMER CONFORMED NAME: INTEGRATED GENERICS INC /NV/ DATE OF NAME CHANGE: 19880824 FORMER COMPANY: FORMER CONFORMED NAME: PATIENT MEDICAL SYSTEMS CORP DATE OF NAME CHANGE: 19880615 8-K 1 INFORMATION REPORT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A1 Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported):November 7, 1997 BIOPHARMACEUTICS, INC. (Exact name of Registrant as specified in its Charter) DELAWARE 1-9370 13-3186327 (State or other (Commission File Number) (I.R.S Employer jurisdiction of I.D. Number) incorporation) 990 Station Road Bellport, New York 11713 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (516-286-5800) N/A (Former name or former address, if changed since last report.) The contents of the FOrm 8K reportes for November 7, 1997, were erroneously filed for that date istead of September 15, 1997, the earliest event reported. A new 8K for September 15, 1997 has been filed containing the information previously filed and other information which was erroneously on the November 7, 1997 filing. Reference is made to the Form 8K of September 15, 1997 for the information concerning the Company's acquisition of Caribbean Medical Testing Center, Inc. on September 15, 1997. The Form 8K for November 7, 1997, as amended hereby may be disregarded. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOPHARMACEUTICS, INC. (Registrant) By: /s/ Edward Fine Edward Fine President, Chief Executive Officer (Signature) Dated: December 2, 1997 -----END PRIVACY-ENHANCED MESSAGE-----